Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Noninvasive biomechanical therapy improves objective and subjective measurements of pain and function in patients with knee osteoarthritis: a retrospective analysis

Lador, Rana; Segal, Ganitb; Kosashvili, Yonac; Drexler, Michaela; Chechik, Ofira; Haim, Amira; Salai, Moshea; Elbaz, Avib; Debi, Ronend

Erratum

The abstract in the article that appeared on page 674 of the November/December 2013 issue of Current Orthopaedic Practice included incorrect information. The corrected abstract appears below:

Background: Biomechanical interventions for the management of knee osteoarthritis (OA) are emerging. AposTherapy is one type of biomechanical therapy that was shown to reduce knee adduction moment and improve gait patterns and clinical symptoms. The purpose of the current study was to further investigate the changes in gait patterns following this biomechanical therapy and to define its possible clinical benefits for patients with knee OA.

Methods: 988 patients with knee OA were evaluated using a computerized gait test as well as with the Western Ontario and McMaster Osteoarthritis Index (WOMAC) and SF-36 Health Survey self-evaluation questionnaires. Following these measurements, the Apos system was individually calibrated to each patient according to his or her gait patterns and clinical evaluation. All patients received exercise guidelines and underwent 4 months of therapy. A second evaluation of gait and clinical symptoms was conducted after four months of therapy.

Results: After 4 months of therapy, a significant improvement was found in all gait parameters (all P<0.01), as well as in the level of pain, function and quality of life (all P<0.01). High correlations were found between the improvement in gait parameters and the improvement in self-evaluation questionnaires.

Conclusions: The examined biomechanical therapy led to a significant reduction in pain and improvement in function, quality of life and gait patterns. These finding support previous findings and deepens the understanding of this new non-invasive biomechanical therapy in patients with knee OA.

Current Orthopaedic Practice. 25(2):103, March/April 2014.

doi: 10.1097/BCO.0000000000000029
DEPARTMENTS: INNOVATIONS IN PRACTICE

Background: Biomechanical interventions for the management of knee osteoarthritis (OA) are emerging. AposTherapy is one type of biomechanical therapy that has been shown to reduce knee adduction moment and improve gait patterns and clinical symptoms. The purpose of the current study was to further investigate the changes in gait patterns after this biomechanical therapy and to define its possible clinical benefits for patients with knee OA.

Methods: Four hundred and twelve patients with knee OA were evaluated using a computerized gait test, as well as the Western Ontario and McMaster Osteoarthritis Index (WOMAC) and the SF-36 Health Survey self-evaluation questionnaires. After these measurements, the Apos system was individually calibrated to each patient according to his or her gait patterns and clinical evaluation. All patients received exercise guidelines and underwent 3 months of therapy. A second evaluation of gait and clinical symptoms was conducted after 3 months of therapy.

Results: After 3 months of therapy, a significant improvement was found in all gait parameters (all P<0.01), as well as in the level of pain, function, and quality of life (all P<0.01). High correlations were found between the improvement in gait parameters and the improvement in self-evaluation questionnaires.

Conclusions: The examined biomechanical therapy led to a significant reduction in pain and improvement in function, quality of life, and gait patterns. These findings support previous findings and deepen the understanding of this new noninvasive biomechanical therapy in patients with knee OA.

aDepartment of Orthopedic Surgery, Sourasky Medical Center, Tel Aviv, Israel.

bAposTherapy Research Group, Herzliya, Israel.

cDepartment of Orthopedic Surgery, Rabin Medical Center, Petah Tikva, Israel.

dDepartment of Orthopedic Surgery, Barzilay Medical Center, Ashkelon, Israel.

Financial Disclosure: Ronen Debi and Avi Elbaz hold shares in AposTherapy. Ganit Segal is a salaried employee of AposTherapy. Ran Lador, Yona Kosashvili, Michael Drexler, Ofir Chechik, Amir Haim, and Moshe Salai are co-researchers in a number of studies. They do not receive and are not entitled to any financial compensation from AposTherapy.

Correspondence to Ronen Debi, MD, Department of Orthopedic Surgery, Barzilay Medical Center, 3rd Hahistadrut St., Ashkelon, 78278, Israel Tel: +972-8-6745631; fax: +972-8-6745779; e-mail: researchdept10@gmail.com.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins